+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

TREMFYA Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TREMFYA Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
HUMIRA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

HUMIRA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
STELARA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

STELARA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Nemolizumab Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Nemolizumab Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Difamilast Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Difamilast Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Abrocitinib Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Abrocitinib Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
OPZELURA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OPZELURA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Hidradenitis Suppurativa (HS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hidradenitis Suppurativa (HS) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 95 Pages
  • Global
From
From
Contact Dermatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Contact Dermatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Inducible Urticaria Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inducible Urticaria Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Prurigo Nodularis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Prurigo Nodularis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Radiation Dermatitis - Epidemiology Insight - 2032 - Product Thumbnail Image

Radiation Dermatitis - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Netherton Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Netherton Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
LY3454738 - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

LY3454738 - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 35 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more